Antinuclear Antibody Spectrum Test Kit (Microarray Chip Method)

Antinuclear Antibody (ANA) testing is a critical tool in the field of autoimmune disease research, as ANAs are autoantibodies that target various nuclear components (such as nucleic acids, nuclear proteins, and ribonucleoproteins) and are closely associated with a range of systemic autoimmune rheumatic diseases (SARDs) and other autoimmune conditions. In research settings, the detection of specific ANA subtypes (e.g., anti-Sm, anti-SSA, anti-dsDNA) plays a key role in studying the pathogenesis, disease progression, and subtype classification of autoimmune disorders—including but not limited to systemic lupus erythematosus (SLE), Sjögren’s syndrome, scleroderma, and myositis.Traditional ANA detection methods, such as indirect immunofluorescence (IIF) or enzyme-linked immunosorbent assay (ELISA), often have limitations: IIF can only provide qualitative screening results without identifying specific antibody subtypes, while ELISA typically requires separate tests for each target, leading to low efficiency, high sample consumption, and prolonged experimental cycles. With the development of microarray technology, microarray chip-based ANA spectrum test kits have emerged as a advanced solution for research applications. These kits leverage the high-throughput nature of microarray platforms to detect multiple ANA subtypes simultaneously from a single sample, addressing the inefficiencies of traditional methods and meeting the growing demand for comprehensive, rapid ANA profiling in autoimmune disease research.This Antinuclear Antibody Spectrum Test Kit (Microarray Chip Method) is designed specifically for research use, focusing on the detection of IgG-class antibodies against nuclear antigens in human serum. It provides researchers with a reliable tool to explore the association between specific ANA subtypes and autoimmune disease phenotypes, supporting preclinical studies, biomarker discovery, and mechanism research in the field of immunology.